相关实验视频
概括
No abstract available in PubMed .
相关概念视频
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
Lonidamine extends lifespan of adult Caenorhabditis elegans by increasing the formation of mitochondrial reactive oxygen species.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2011
Same author
Genetic population structure, fitness variation and the importance of population history in remnant populations of the endangered plant Silene chlorantha (Willd.) Ehrh. (Caryophyllaceae).
Plant biology (Stuttgart, Germany)·2011
Same author
The phytochemical glaucarubinone promotes mitochondrial metabolism, reduces body fat, and extends lifespan of Caenorhabditis elegans.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2011
Same author
Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association·2011
Same author
Differential effects of resveratrol and SRT1720 on lifespan of adult Caenorhabditis elegans.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2010
Same author
Physical activity does not influence the effect of antioxidant supplementation at nutritional doses on the incidence of impaired fasting glucose: a 7.5 year post-hoc analysis from the SU.VI.MAX study.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2010
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026